1 / 7

Future outlook of Human Chorionic Gonadotropin (hCG) Market

Rise in incidence of infertility-related problems in both the genders drive the growth of the global hCG market. In addition, upsurge in the adoption of hCG hormone in pain management and weight loss propel the market growth.

Hemant1
Download Presentation

Future outlook of Human Chorionic Gonadotropin (hCG) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Human Chorionic Gonadotropin (hCG) Market To Receive Overwhelming Hike in Revenues By 2030 Human Chorionic Gonadotropin (hCG) Market by Technology (Natural Source Extraction, and Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), and End User (Fertility Clinics, Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025

  2. Why Allied Market Research? FREQUENTLY ASKED QUESTIONS? INFALLIBLE METHODOLOGY To ensure high-level data integrity, accurate analysis, and impeccable forecasts ANALYST SUPPORT For complete satisfaction CUSTOMIZATION On-demand customization of scope of the report to exactly meet your needs TARGETED MARKET VIEW Targeted market view to provide pertinent information and save time of readers Q1. Who are the leading market players active in the Human Chorionic Gonadotropin (hCG) Market? Q2. What are the current trends that will influence the market in the next few years? Q3. What are the driving factors, restraints, and opportunities in the market? Q4. What can be the challenges for the Human Chorionic Gonadotropin (hCG) Market in future? Q5. Does the Human Chorionic Gonadotropin (hCG) Market company is profiled in the report?

  3. Overview Rise in incidence of infertility-related problems in both the genders drive the growth of the global hCG market. In addition, upsurge in the adoption of hCG hormone in pain management and weight loss propel the market growth. Furthermore, incorporation of recombinant technology for the development of hCG is anticipated to offer lucrative opportunities for the market growth in the near future. Based on technology, the market is divided into natural source extraction and recombinant technology. The recombinant technology segment is expected to register the highest growth rate during the forecast period. However, the natural source extraction segment dominated the global market in 2017 and is anticipated to remain dominant throughout the forecast period. This is attributed to easy and low-cost availability of hCG from pregnant womens urine and placenta cells.

  4. Segments In terms of revenue, the global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End Users, and Regions. By Technology - Based on technology, the market is divided into natural source extraction and recombinant technology. The recombinant technology segment is expected to register the highest growth rate during the forecast period. However, the natural source extraction segment dominated the global market in 2017 and is anticipated to remain dominant throughout the forecast period. By Therapeutic Area - Based on the therapeutic area, the global market is classified into female infertility treatment, oligospermic treatment, male hypogonadism, and others. Male hypogonadism segment is anticipated to witness highest growth rate in the global market, owing to high susceptibility of geriatric population to hypogonadism.

  5. Geography North America dominated the Human Chorionic Gonadotropin (hCG) Market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position.

  6. Key Market Players • The key players operating in the global Human Chorionic Gonadotropin (hCG) Market are • Bristol Myers Squibb Company • Ferring Pharmaceuticals Inc • Merck & Co., Inc • Fresenius Kabi AG • Cigna • Sun Pharmaceutical Industries Ltd • Lee BioSolutions Inc • Sanzyme • Scripps Laboratories • LUPIN

  7. An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans. A comprehensive analysis of factors that drive and restrain the growth of the global is provided. The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value. Key Findings of the Human Chorionic Gonadotropin (hCG) Market: Find out more at the Allied Market Report store https://www.alliedmarketresearch.com/human-chorionic-gonadotropin-HCG-market

More Related